Literature DB >> 24460288

Clinico-pathology of lung cancer in a regional cancer center in Northeastern India.

Sanjeet Kumar Mandal1, Thaudem Tomcha Singh, Takhenchangbam Dhaneshor Sharma, Venkatesan Amrithalingam.   

Abstract

BACKGROUND: Globally, there have been important changes in trends amongst gender, histology and smoking patterns of lung cancer cases.
MATERIALS AND METHODS: This retrospective study was conducted on 466 patients with lung cancer who were registered in Regional Cancer Center, Regional Institute of Medical Sciences, Manipur from January 2008 to December 2012.
RESULTS: Most were more than 60 years of age (67.8%) with a male: female ratio of 1.09:1. Some 78.8% of patients were chronic smokers with male smoker to female smoker ratio of 1.43:1. Consumption of alcohol was found in 29.4%, both smoking and alcohol in 27.5%, betel nut chewing in 37.9% and tobacco chewing in 25.3%. A history of tuberculosis was present in 16.3% of patients. The most frequent symptom was coughing (36.6%) and most common radiological presentation was a mass lesion (70%). Most of the patients had primary lung cancer in the right lung (60.3%). The most common histological subtype was squamous cell carcinoma (49.1%), also in the 40-60 year age group (45.9%), more than 60 year age group (51.6%), males (58.1%) and females (41.8%). As many as 91.9% of squamous cell carcinoma patients had a history of smoking. About 32.5% of patients had distant metastasis at presentation with brain (23.8%) and positive malignant cells in pleural effusions (23.1%) as common sites. The majority of patients were in stage III (34.4%), stage IV (32.5%) and stage II (30.2%).
CONCLUSIONS: Our analysis suggests that the gender gap has been narrowed such that about half of the patients diagnosed with lung cancer are women in this part of India. This alarming rise in female incidence is mainly attributed to an increased smoking pattern. Squamous cell carcinoma still remains the commonest histological subtype. Most of the patients were elderly aged and presented at locally or distantly advanced stages.

Entities:  

Mesh:

Year:  2013        PMID: 24460288     DOI: 10.7314/apjcp.2013.14.12.7277

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

Review 1.  Translatable gene therapy for lung cancer using Crispr CAS9-an exploratory review.

Authors:  Jishnu Nair; Abhishek Nair; Soundaram Veerappan; Dwaipayan Sen
Journal:  Cancer Gene Ther       Date:  2019-06-20       Impact factor: 5.987

2.  Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.

Authors:  Anant Mohan; Avneet Garg; Aditi Gupta; Satyaranjan Sahu; Chandrashekhar Choudhari; Vishal Vashistha; Ashraf Ansari; Rambha Pandey; Ashu Seith Bhalla; Karan Madan; Vijay Hadda; Hariharan Iyer; Deepali Jain; Rakesh Kumar; Saurabh Mittal; Pawan Tiwari; Ravindra M Pandey; Randeep Guleria
Journal:  Lung India       Date:  2020 May-Jun

Review 3.  Nivolumab - Pearls of Evidence.

Authors:  Pratishtha B Chaudhari
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec

4.  [Lung cancer in Eastern Morocco: where do we stand?]

Authors:  Karam Yahya Belmokhtar; Mariam Tajir; Redouane Boulouiz; Amal Bennani; Sami Aziz Brahmi; Ihsan Alloubi; Hatim Kouismi; Imane Kamaoui; Imane Skiker; Said Afqir; Naima Abda; Mohammed Bellaoui; Loubna Mezouar
Journal:  Pan Afr Med J       Date:  2019-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.